secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K/A
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001628280-25-045385
Event type: leadership
Sentiment:  neutral
Materiality: 0.90
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Beauty Health Company CEO Marla Beck Terminated Without Cause, Enters Separation Agreement
--------------------------------------------------------------------------------

- Marla Beck terminated as CEO, President, and director effective September 30, 2025, without cause and with no disagreement on Company matters.
- Separation agreement provides 18 months of base salary continuation, prorated 2025 annual bonus, and COBRA premium reimbursement for up to 18 months.
- Performance share units with a grant-date value of $1,700,000 vest fully on the separation date.
- Beck will serve as a consultant from October 1 through December 31, 2025, receiving $250,000 paid bi-weekly and counting toward 2025 annual incentive plan.
- Company will reimburse up to $10,000 in legal fees; Beck signed a general release of all claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828025045385/0001628280-25-045385-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828025045385/skin-20250926.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-045385

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer